Oak Thistle LLC’s Tandem Diabetes Care TNDM Stock Holding History

Oak Thistle LLC’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,557	Closed	-$303K	–	438
2024 Q1	$303K	Sell	8,557 -9,694	-53%	-$260K	0.27%	170
2023 Q4	$540K	Buy	+18,251	New	+$379K	0.16%	272
2023 Q3	–	Sell	-24,643	Closed	-$605K	–	610
2023 Q2	$605K	Buy	24,643 +16,492	+202%	+$531K	0.32%	125
2023 Q1	$331K	Sell	8,151 -939	-10%	-$38.9K	0.2%	236
2022 Q4	$409K	Buy	+9,090	New	+$412K	0.88%	26
2022 Q2	–	Sell	-1,738	Closed	-$202K	–	404
2022 Q1	$202K	Buy	+1,738	New	+$203K	0.11%	348

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Oak Thistle LLC's TNDM Position: Q2 2024 in Review

Oak Thistle LLC sold out of Tandem Diabetes Care (TNDM) in Q2 2024, closing a stake of 8,557 shares — an estimated $303K sold.

Oak Thistle LLC first reported a position in TNDM in Q1 2022 and held it in 6 quarters. The position peaked at $605K in Q2 2023. 317 funds tracked by Wall St. Rank hold TNDM as of Q2 2024.

Oak Thistle LLC reported no remaining Tandem Diabetes Care position as of Q2 2024 after selling out during the quarter.
Oak Thistle LLC sold 8,557 Tandem Diabetes Care shares in Q2 2024, an estimated $303K.
Oak Thistle LLC first reported a position in Tandem Diabetes Care in Q1 2022 and held it in 6 quarters.
Oak Thistle LLC's Tandem Diabetes Care position peaked at $605K in Q2 2023.
317 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2024.

Based on Oak Thistle LLC's 13F filing for Q2 2024, filed 6 Aug 2024.